Monday, December 20, 2010 3:05:15 PM
If my (bad) memory is correct that is at least the second if not the third potential IPF compound they have licensed/acquired in past couple years. With Actelion Tracleer failing in IPF and Letaris having the same MOA I imagine its prospects have dimmed. But obviously someone (besides me 
) sees a potentially very lucrative opportunity in this field. I think a good strategy for ITMN would be to try and license/acquire some early stage candidates in that field. With them having the only approved compound they have a little extra time to pick a more potent/more promising agent too. Actelion didn't fair too well trying to build a pipeline/extend their dominance in PAH it will be interesting if ITMN does a better job (if they aren't gobbled up by someone).
) sees a potentially very lucrative opportunity in this field. I think a good strategy for ITMN would be to try and license/acquire some early stage candidates in that field. With them having the only approved compound they have a little extra time to pick a more potent/more promising agent too. Actelion didn't fair too well trying to build a pipeline/extend their dominance in PAH it will be interesting if ITMN does a better job (if they aren't gobbled up by someone).
Join the InvestorsHub Community
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
